1. Establishment of the MID‐NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan. Issue 10 (29th August 2019) Authors: Yamaguchi, Mitsune; Inomata, Satomi; Harada, Sayoko; Matsuzaki, Yu; Kawaguchi, Maiko; Ujibe, Mayuko; Kishiba, Mari; Fujimura, Yoshiaki; Kimura, Michio; Murata, Koichiro; Nakashima, Naoki; Nakayama, Masaharu; Ohe, Kazuhiko; Orii, Takao; Sueoka, Eizaburo; Suzuki, Takahiro; Yokoi, Hideto; Takahashi,... Journal: Pharmacoepidemiology and drug safety Issue: Volume 28:Issue 10(2019) Page Start: 1395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan. Issue 1 (18th September 2021) Authors: Nishioka, Kinue; Makimura, Tomomi; Ishiguro, Akihiro; Nonaka, Takahiro; Yamaguchi, Mitsune; Uyama, Yoshiaki Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 1(2022) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗